FDA Inspection
Zhejiang Jingwei Pharmaceutical Co., Ltd.Zhejiang Jingwei Pharmaceutical Co., Ltd. – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns Zhejiang Jingwei Pharmaceutical Co., Ltd., with an inspection on March 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d77438d5-afeb-412d-9c55-24d797529e53
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1086689
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Zhejiang Jingwei Pharmaceutical Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| November 22, 2024 | Not classified | Office of Inspections and Investigations | |
| March 2, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Jingwei Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.